| Identification | Back Directory | [Name]
Emorfazone | [CAS]
38957-41-4 | [Synonyms]
PH011085
Emorfazone
Emorfazone USP/EP/BP
4-ethoxy-2-Methyl-5-Morpholinopyridazin-3(2H)-one | [EINECS(EC#)]
254-220-9 | [Molecular Formula]
C11H17N3O3 | [MDL Number]
MFCD00866118 | [MOL File]
38957-41-4.mol | [Molecular Weight]
239.27 |
| Chemical Properties | Back Directory | [Melting point ]
89-91° | [Boiling point ]
381.93°C (rough estimate) | [density ]
1.1771 (rough estimate) | [refractive index ]
1.5700 (estimate) | [pka]
1?+-.0.20(Predicted) |
| Hazard Information | Back Directory | [Description]
Emorfazone is an analgesic agent with a potency similar to aminopyrine, useful
in the treatment of low back pain and similar musculoskeletal disorders. | [Originator]
Morishita (Japan) | [Uses]
Emorfazone has been known to comprise of 5α-?reductase inhibitor. It consists of postsurgical adhesion inhibitors that contain anti-inflammatory agents and anticoagulants and hyaluronate. | [Definition]
ChEBI: Emorfazone is an organic molecular entity. | [Brand name]
PENTOIL |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|